| http://www.w3.org/ns/prov#value | - The AAV vector has been evaluated in gene therapy clinical trials for cystic fibrosis, hemophilia, Parkinson's disease, Duchenne's muscular dystrophy and other diseases.Sands undertook the new research attempting to confirm his previous findings and to determine how the AAV vector might encourage tumor development.
|
